Custom-Made vaccine takes on ovarian cancer
Disease control
Completed
This Phase 1 trial tested a personalized immunotherapy called TG4050 in 64 women with advanced ovarian, fallopian tube, or peritoneal cancer who had completed standard chemotherapy and were in complete remission. The treatment is made from each patient's unique tumor mutations an…
Phase: PHASE1 • Sponsor: Transgene • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC